Management of Chronic Fatigue in Hemodialysis Patients

Introduction to Fatigue Management

• The American Society of Nephrology recommends prioritizing aerobic exercise as the primary intervention for fatigue in hemodialysis patients, followed by cognitive behavioral therapy, while optimizing dialysis adequacy and correcting anemia, as SSRIs should not be used as first-line treatment due to lack of consistent benefit and increased adverse effects 1, 2, 3.

Routine Assessment and Recognition

• The National Kidney Foundation suggests implementing routine symptom screening every 1-3 months using validated tools to identify fatigue early, as it affects at least half of patients on long-term dialysis and is associated with higher mortality 1, 5.
• Documenting fatigue in the medical record and integrating it into the overall clinical assessment is crucial, as treatment is initiated infrequently even when symptoms are identified 1, 2.

First-Line Non-Pharmacologic Interventions

• The American College of Sports Medicine recommends prescribing moderate-intensity aerobic exercise for at least 150 minutes per week as the primary intervention, as moderate-quality evidence demonstrates this reduces fatigue and depressive symptoms in hemodialysis patients 3, 4.
• Aerobic exercise provides dual benefit by simultaneously addressing fatigue and the 40% prevalence of depression in dialysis patients, which often coexist and compound each other 1, 3.
• The American Psychological Association suggests referring patients for cognitive behavioral therapy (CBT) as it has proven efficacy in reducing depression, which frequently contributes to fatigue in hemodialysis patients 3, 4, 6.

Optimize Dialysis Prescription

• The European Renal Association recommends ensuring adequate dialysis delivery with minimum three times weekly sessions, as inadequate dialysis contributes to uremic symptoms including fatigue 6.
• Consider offering in-center short frequent hemodialysis (more than 3 times weekly) or home long hemodialysis (6-8 hours, 3-6 nights per week) after discussing individual patient preferences, as these regimens improve blood pressure control, anemia management, and quality of life in selected patients 8.

Correct Underlying Medical Factors

• The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend initiating erythropoiesis-stimulating agents (ESAs) when hemoglobin is <10 g/dL, using the lowest dose sufficient to reduce transfusion need, as correcting anemia directly impacts fatigue and treatment tolerance 4.

Pharmacologic Approaches: Use With Extreme Caution

• The American Society of Nephrology advises against using SSRIs as first-line treatment for fatigue, as existing small randomized placebo-controlled trials have not shown consistent benefit over placebo in hemodialysis patients 3, 4, 6.

Address Psychosocial Factors

• The National Institute of Mental Health suggests providing iterative, culturally sensitive education and emotional support, recognizing that emotional preparedness is as important as educational preparedness 4, 6.
• Consider mental health professional input for emotional support to address the psychological burden of fatigue 4.

Common Pitfalls to Avoid

• The American Medical Association recommends not dismissing fatigue as an expected part of dialysis—it is a treatable symptom that significantly impacts mortality and quality of life 1.
• Avoid prescribing SSRIs without first optimizing dialysis adequacy, correcting anemia, and attempting non-pharmacological interventions 6.
• Do not overlook the impact on caregivers, as symptom burden extends beyond the patient to family members and can lead to caregiver burnout 5, 4.